“2 “Strong Buy” Penny Stocks That Could Deliver Massive Returns”
January 6, 2021
“9 Meters Biopharma (NMTR)…
Turning now to the rest of the Street, other analysts are on the same page. With 4 Buys and no Holds or Sells, the word on the Street is that NMTR is a Strong Buy. Given its $4.33 average price target, upside of 386% could be in store for investors…
Orchard Therapeutics (ORTX)…
Do other analysts agree with Nierengarten? They do. Only Buy ratings, 3, in fact, have been issued in the last three months. Therefore, ORTX gets a Strong Buy consensus rating. At $15, the average price target indicates shares could appreciate by 241% in the year ahead…”
https://finance.yahoo.com/news/2-strong-buy-penny-stocks-174115335.html